CHHE — China Health Industries Holdings Income Statement
0.000.00%
- $0.00m
- $5.52m
- $0.11m
Annual income statement for China Health Industries Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.28 | 9.93 | 6.49 | 0 | 0.112 |
Cost of Revenue | |||||
Gross Profit | 7.04 | 7.27 | 3.64 | -0.001 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 4.71 | 5.04 | 4.63 | 1.65 | 1.95 |
Operating Profit | 4.56 | 4.89 | 1.86 | -1.65 | -1.84 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.69 | 5.02 | 2.02 | -0.351 | -0.409 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.31 | 3.55 | 1.29 | -0.354 | -0.409 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.31 | 3.55 | 1.29 | -0.354 | -0.409 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.31 | 3.55 | 1.29 | -0.354 | -0.409 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.05 | 0.054 | 0.02 | -0.005 | -0.006 |